RSL1D1 and colorectal carcinoma: Furthermore, IF assays and WB showed that NAM treatment alleviated RSL1D1 knockdown-mediated increases in nuclear STAT3 and p-STAT3 in CRC cells after RSL1D1 knockdown (Fig. 8A, B).